ARTICLE | Company News
Eyetech Pharmaceuticals, Isis deal
June 28, 2004 7:00 AM UTC
ISIS received a $1 million milestone from EYET under a 2002 deal in which EYET licensed from ISIS patents that cover the development and manufacturing of EYET's Macugen pegaptanib (see BioCentury, Ja...